関連する実験動画
Updated: May 10, 2026

09:26
Transabdominal Ultrasound for Pregnancy Diagnosis in Reeves' Muntjac Deer
Published on: January 7, 2014
10.4K
ミニチュア・エクイードにおけるディストキアの遡及評価: 78例 (2002年−2023年)
Ari Merari1, Langdon Fielding1
1Loomis Basin Equine Medical Center, Penryn, California, USA.
まとめ
ミニチュア馬馬は ダイストキアの生存率が高く 経分娩で回復することが多い. しかし,小児の生存率は低いまま,改善された介入と訓練の必要性を強調しています.
科学分野:
- 獣医学
- 馬の繁殖
- 純粋な科学
背景:
- ダイストキア症は馬の繁殖に重大な課題をもたらします.
- ミニチュア馬は,その大きさのせいで, 仔犬を産む時に独特の合併症に直面することがあります.
研究 の 目的:
- ミニチュア・エクイッドのディストキアの症例を総合的に分析する.
- メアとフールの生存に影響を与える重要な要因を特定する.
- 異なる修正方法の有効性を評価する.
主な方法:
- ミニチュア・エクイードにおける 78 件のディストキア症例を分析した遡及的研究.
- 2002年1月から2023年6月までのデータ
- 大きな馬の紹介病院とフィールドサービスが関与しました.
主要な成果:
- マレの生存率は94%でしたが,小児の生存率は17%でした.
- 常見のディストキアの原因は,異常な肢体 (27%),首の屈折 (23%),尾部 (17%).
- コントロールされたまたは助産された陰道出産はほとんどの症例 (80%) で,帝王切開による出産は17%であった.
結論:
- ミニチュア馬馬は ダイストキアに強い抵抗力を持っています
- 大抵の場合 陰道経由の投与方法が有効です
- 仔羊の生存率を高めるには 仔羊のケアと管理の緊急の進展が不可欠です
関連する概念動画
Effects of EDTA on End-Point Detection Methods
Different methods, such as visual observance of metal-ion indicators, spectroscopic techniques, and potentiometric methods, can determine the endpoint of an EDTA titration.
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a result, EDTA...
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a result, EDTA...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

